✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Edwards Lifesciences Corp

Common Name
Edwards Lifesciences
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
16,000
Ticker
EW
Exchange
New York Stock Exchange
Description
Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing...

Edwards Lifesciences's Financial Statements Preview

Below are the financial statements of Edwards Lifesciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 2024-01-01 - 2024-12-31
2023 2023-01-01 - 2023-12-31
2022 2022-01-01 - 2022-12-31
Net sales
5,439.5a
5,010a
4,464a
Cost of sales
-1,117.5a
-978.4a
-723.7a
Gross profit
4,322a
4,031.6a
3,740.3a
Selling, general, and administrative expenses
-1,789.2a
-1,582.5a
-1,357.6a
Research and development expenses
-1,053a
-962.9a
-843.6a
Intellectual property agreement and certain litigation expenses
-40.4a
-203.5a
-15.8a
Change in fair value of contingent consideration liabilities
0a
-26.2a
-35.8a
Restructuring charges, separation costs, and other
-61a
0a
-60.7a
Other operating income, net
-0.3a
0a
0a
Operating income
1,378.7a
1,308.9a
1,498.4a
Interest expense
-19.8a
-17.6a
-19.2a
Interest income
-120.3a
-67.2a
-35.5a
Other non-operating income, net
-68.9a
-13.9a
-4.8a
Income from continuing operations before provision for income taxes
1,548.1a
1,372.4a
1,519.5a
Provision for income taxes
-152.1a
-152.4a
-195.5a
Net income from continuing operations
1,396a
1,220a
1,324a
Income from discontinued operations, net of tax
2,773.7a
179.4a
197.9a
Net income
4,169.7a
1,399.4a
1,521.9a
Net loss attributable to noncontrolling interest
-4.9a
-3a
0a
Net income attributable to Edwards Lifesciences Corporation
4,174.6a
1,402.4a
1,521.9a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Edwards Lifesciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Edwards Lifesciences's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?